In this Review, Münzel and colleagues discuss the available mechanistic, biomarker, preclinical and clinical data on the cardiovascular effects of nicotine-containing products, define a hierarchy of ...
Diagnosis‑related failures and medical treatment issues continue to drive the majority of cardiology malpractice claims, according to a new analysis. A review of 321 closed cases from 2010 to 2025 by ...
The statistics are clear: GLP-1 medications can have a dramatic effect on cardiovascular health. Recent research has shown both semaglutide and tirzepatide — the active ingredients in Ozempic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results